Nicotinamide: Clinical Trials

2 trials for Nicotinamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Active not recruiting 1

Follow Nicotinamide: new trials by email Literature Review of Nicotinamide trials Research Report on Nicotinamide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Nicotinamide, Placebo - Fatty Liver, Obesity
Phase 2RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau302024-04-232025-11-18
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
Nicotinamide treatment, placebo treatment - Acute Kidney Injury, Septic Shock
Phase 3Active not recruitingCentre Hospitalier Universitaire, Amiens3102020-10-012025-08-24

Narrower conditions

Acute Kidney Injury (1)  ·  Fatty Liver (1)  ·  Liver Cirrhosis (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Shock, Septic (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Body Weight (1)  ·  Digestive System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fibrosis (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Kidney Diseases (1)  ·  Liver Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)

Interventions

Niacinamide (1)

Sponsors

Centre Hospitalier Universitaire, Amiens (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)

Countries

France (1)  ·  Spain (1)

NIH funding

2023 (1)